Detalles de la búsqueda
1.
(Pre)treatment risk factors for late fatigue and fatigue trajectories following radiotherapy for breast cancer.
Int J Cancer
; 153(9): 1579-1591, 2023 11 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37403702
2.
Reply to: Comments on "(Pre)treatment risk factors for late fatigue and fatigue trajectories following radiotherapy for breast cancer".
Int J Cancer
; 154(4): 759-761, 2024 Feb 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-37908014
3.
Survivorship Data in Prostate Cancer: Where Are We and Where Do We Need To Be?
Eur Urol Open Sci
; 59: 27-29, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-38298764
4.
Health Policy for Prostate Cancer Early Detection in the European Union and the Impact of Opportunistic Screening: PRAISE-U Consortium.
J Pers Med
; 14(1)2024 Jan 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-38248785
5.
How Can We Improve Patient-Clinician Communication for Men Diagnosed with Prostate Cancer?
Eur Urol Open Sci
; 62: 1-7, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38585208
6.
Systematic Review on the Cost Effectiveness of Prostate Cancer Screening in Europe.
Eur Urol
; 2024 May 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-38789306
7.
EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer-2024 Update. Part I: Screening, Diagnosis, and Local Treatment with Curative Intent.
Eur Urol
; 2024 Apr 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-38614820
8.
EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer. Part II-2024 Update: Treatment of Relapsing and Metastatic Prostate Cancer.
Eur Urol
; 2024 Apr 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-38688773
9.
European survey on the use of patient contact shielding during radiological examinations.
Insights Imaging
; 14(1): 108, 2023 Jun 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-37336849
10.
Comparing symptom reporting by prostate cancer patients and healthcare professionals in the international multicentre REQUITE study.
Radiother Oncol
; 178: 109426, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36442608
11.
Impact of Epithelial Histological Types, Subtypes, and Growth Patterns on Oncological Outcomes for Patients with Nonmetastatic Prostate Cancer Treated with Curative Intent: A Systematic Review.
Eur Urol
; 84(1): 65-85, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37117107
12.
A Systematic Review of the Efficacy and Toxicity of Brachytherapy Boost Combined with External Beam Radiotherapy for Nonmetastatic Prostate Cancer.
Eur Urol Oncol
; 2023 Dec 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-38151440
13.
Best Current Practice and Research Priorities in Active Surveillance for Prostate Cancer-A Report of a Movember International Consensus Meeting.
Eur Urol Oncol
; 6(2): 160-182, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36710133
14.
Patient- and Tumour-related Prognostic Factors for Urinary Incontinence After Radical Prostatectomy for Nonmetastatic Prostate Cancer: A Systematic Review and Meta-analysis.
Eur Urol Focus
; 8(3): 674-689, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33967010
15.
Evaluation of Oncological Outcomes and Data Quality in Studies Assessing Nerve-sparing Versus Non-Nerve-sparing Radical Prostatectomy in Nonmetastatic Prostate Cancer: A Systematic Review.
Eur Urol Focus
; 8(3): 690-700, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-34147405
16.
Overview of health-related quality of life and toxicity of non-small cell lung cancer patients receiving curative-intent radiotherapy in a real-life setting (the REQUITE study).
Lung Cancer
; 166: 228-241, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35334417
17.
The correlation between pre-treatment symptoms, acute and late toxicity and patient-reported health-related quality of life in non-small cell lung cancer patients: Results of the REQUITE study.
Radiother Oncol
; 176: 127-137, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-36195214
18.
Systematic Review of Active Surveillance for Clinically Localised Prostate Cancer to Develop Recommendations Regarding Inclusion of Intermediate-risk Disease, Biopsy Characteristics at Inclusion and Monitoring, and Surveillance Repeat Biopsy Strategy.
Eur Urol
; 81(4): 337-346, 2022 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-34980492
19.
Treatment time and circadian genotype interact to influence radiotherapy side-effects. A prospective European validation study using the REQUITE cohort.
EBioMedicine
; 84: 104269, 2022 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-36130474
20.
The Key Role of Patient Involvement in the Development of Core Outcome Sets in Prostate Cancer.
Eur Urol Focus
; 7(5): 943-946, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34602368